BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8030708)

  • 41. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-Kell in pregnancy.
    Vaughan JI; Warwick R; Welch CR; Letsky EA
    Br J Obstet Gynaecol; 1991 Sep; 98(9):944-5. PubMed ID: 1911618
    [No Abstract]   [Full Text] [Related]  

  • 43. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The management of hemolytic disease in the fetus and newborn.
    Bowman J
    Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.
    Saade GR; Moise KJ; Belfort MA; Hesketh DE; Carpenter RJ
    Fetal Diagn Ther; 1993; 8(3):161-4. PubMed ID: 8240686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythroblastosis and reticulocytosis in anemic fetuses.
    Nicolaides KH; Thilaganathan B; Rodeck CH; Mibashan RS
    Am J Obstet Gynecol; 1988 Nov; 159(5):1063-5. PubMed ID: 3189438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
    Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
    Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evaluation of extended analysis of serum, amniotic fluid and cardiotocography in the management of pregnancy complicated by immunization in Rh or Kell antigens.
    Woytoń J; Narczewska B; Gajewska E; Baranowski H; Kwoczyńska K; Dzierzkowa-Borodej W; Partyka T; Bochenek S; Lochocka E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1131-7. PubMed ID: 107916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A successfully treated case of congenital hydrops by Kell-alloimmunization].
    Görbe E; Hajdú J; Lipták M; Machay T; Molnár V; Czinyéri J; Papp Z
    Orv Hetil; 1992 Dec; 133(49):3151-2. PubMed ID: 1454359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
    Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Causes of fetal anemia in hemolytic disease due to anti-K.
    Daniels G; Hadley A; Green CA
    Transfusion; 2003 Jan; 43(1):115-6. PubMed ID: 12519439
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe anemia due to Kell alloimmunization.
    Giannacopoulou CH; Relakis K; Kalmanti M
    Haematologia (Budap); 1997; 28(3):173-5. PubMed ID: 9283918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fetal death and benign hemolytic disease of the newborn from anti-Cellano alloimmunization: 2 new case reports].
    Rigal D; Juron-Dupraz F; Biggio B; Jouvenceaux A
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):101-4. PubMed ID: 7071459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal anti-Kell isoimmune hemolytic disease with spherocytes.
    Merlob P; Reisner SH; Zaizov R
    Pediatr Hematol Oncol; 1986; 3(2):175-8. PubMed ID: 3153228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.